Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061780) titled 'A trial to evaluate the efficacy and safety of Sacubitril/valsartan treatment in patients with difficult-to-control hypertension' on June 3.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -no one is blinded Control - Active

Primary Sponsor: Institute - Yokohama Sakae Kyosai Hospital

Condition: Condition - Patients with essential hypertension who have poor blood pressure control despite combination therapy with ARBs and CCBs Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To evaluate the efficacy and safety of adding Sacubitril/Valsartan to the regimen in patients with uncontrolled hypertension despite combination therapy with angiotensin II receptor blockers (ARBs) and calcium channel blockers (CCBs), compared with adding a diuretic. Basic objectives2 - Safety,Efficacy

Intervention: Interventions/Control_1 - Sacubitril/Valsartan Group Interventions/Control_2 - Indapamido Group

Eligibility: Age-lower limit - 18 years-old =180 mmHg or diastolic blood pressure >=110 mmHg). 4. Patients with clearly secondary hypertension due to underlying conditions such as primary aldosteronism, renovascular hypertension, or pheochromocytoma 5. Patients requiring renal replacement therapy or with severe renal impairment (eGFR3.5 g/gCr) 7. Severe hepatic impairment (e.g., cirrhosis, Child-Pugh Class C), 8.NYHA Class III or higher, poorly controlled severe chronic heart failure 9. End-stage malignant disease 10. Patients with severe infections 11. Pregnancy 12. Patients deemed unsuitable for enrollment by the attending physician due to poor adherence to medical visits or medication Target Size - 140

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 04 Month 30 Day Date of IRB - 2026 Year 03 Month 16 Day Anticipated trial start date - 2026 Year 06 Month 03 Day Last follow-up date - 2027 Year 12 Month 01 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070696

Disclaimer: Curated by HT Syndication.